Roche named hematologist Mark Dawson, an expert in cancer epigenetics, to lead its pharma research and early development unit effective May 1.
Longevity News
The Swiss drugmaker has plucked an experienced scientist from Down Under to lead its early research efforts.
Source: FierceBiotech - All • Published: 20 Feb 2026, 21:00
Continue exploring
Related longevity signals
Longevity TechnologyClaremedica’s digital test finds 90% of new dementia cases earlyA report on a primary care group’s adoption of a digital cognitive assessment and what readers will learn about its implementation and uptake.Longevity TechnologyRetro Biosciences expands early trial for drug targeting Alzheimer’s, Parkinson’sA short news article about an early-stage clinical trial expansion testing higher doses of a candidate neurodegenerative drug, outlining safety and dosing goals and what readers can expect to learn.Frontiers - HealthEarly systemic immune-inflammation index is associated with mortality and functional outcome in brainstem hemorrhageEarly systemic immune-inflammation index trajectories in acute brainstem hemorrhage — a clinical research article preview offering prognostic biomarker insights and patient risk stratification.Frontiers - HealthEnhancing early diabetic retinopathy detection: a fine-tuned NASNet framework with robust validation and external generalizationEarly diabetic retinopathy screening using a fine-tuned deep‑learning NASNet framework; a technical article detailing model development, validation, and generalization.